chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Admission Date: 9/30/2022 Discharge Date: 10/5/2022   Clinical Narrative:   Admitted with Covid Pneumonia/exacerbation of COPD. Doing well after Decadron/Remdesivir/MDIs/Pulmonary Hygiene/care. Home today with continued attention to symptomatic management.   Please see the following problem-list oriented Hospital Course below:   * Pneumonia due to COVID-19 virus Assessment & Plan Will give Decadron, vitamin- C, zinc, Pepcid and Remdesivir.  Lovenox prophylaxis.  Follow-up chest x-ray tomorrow morning.    10/2....  Continue IV remdesivir, Decadron, oxygen as per protocol on vitamins Saturating 97% on 1 L nasal cannula   10/3.....  Chest x-ray today shows worsened or persistent filtrates however patient shows clinical improvement, she is presently on room air saturating 96%   Procalcitonin is normal and CRP improved     10/5 - consistencies steady improvement during her hospital stay.  Doing well.  Oxygen needs back to baseline on room air.  Discharge planning.  Acute respiratory failure with hypoxemia Assessment & Plan Titrate oxygen to effect.  Encourage prone positioning.  Encourage pulmonary toilet.  Bronchodilator p.r.n.  Will give Lasix IV now for diuresis   A result of COVID-19 pneumonia Continue treatment as above Encourage prone positioning     10/5 - continues to do well.  Will finish remdesivir today.  Discharge planning.  Oxygen needs at baseline.  On room air.
This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient. A male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for Covid-19 immunisation. Relevant medical history included: "smoker" (unspecified if ongoing), notes: he was a smoker for 40 years. The patient's concomitant medications were not reported. The following information was reported: TASTE DISORDER (non-serious), outcome "unknown", described as "had a weekend in which things didn't taste good"; ASTHENIA (non-serious), outcome "unknown", described as "felt a little weak"; RASH (non-serious), outcome "unknown", described as "rashes on his left arm that would come and go". Relevant laboratory tests and procedures are available in the appropriate section. Additional information: The reporter stated he was exposed to Covid-19 between the first and second doses of Pfizer Covid-19 vaccine. The reporter stated he was around someone who had a mask on as well as he did and that person tested positive for Covid-19 but he tested negative. Caller stated he had a weekend in which things didn't taste good, felt a little weak, rashes on his left arm that would come and go caller stated he haven't had any rashes in a while. No follow-up attempts are possible. No further information is expected.
I received the pfizer covid 19 vaccine on 02/06/2022. At first I got a funny taste in my mouth from it I was a little light headed but that went away. On the 8th of February I woke up at 2:30 or so in the morning both my hands where swollen and hurting really bad I had to have my son cut my rings off cause no matter what I tried they would not slip over my knuckles. I had a high fregacery sound in my left ear. That has not gone away and can't hear to good out of it. I can not get any relief from it. I have never had a problem with my ears no infections in them even as a child. I reported this to my doctor who in turn told me it's because I'm getting older. I do not believe that I just turned 50 and never had anything wrong with my ears period. I know this is from the vaccine period. Now I don't know what to do I can not function with this high pitch fregacery in my ear. I have to get my teeth to get a little relief which in turn I have broke 2 teeth doing this. This is not fare.  n
Two days after my vaccine I started to have a flare up on my right foot. By the next day both feet were bothering me. I didn't take anything for it. 04/25/2022 I ended up having to take an ambulance to the ER because I could not walk. The doctor looked at my history and I told him it was Pseudogout. He prescribed steroids' which seems to help. After taking the steroids' I felt better after about 3 days.
Breakthrough case admission after 4 vaccines Pfizer 1/27/21 Lot# El9261;  Pfizer 2/17/21 Lot# El9265: Pfizer 9/27/21 Lot# FF8839;  Pfizer 4/14/22 Lot# FK9894;
Information has been received from a registered nurse, concerning a 71 year old female patient with osteoporosis, hypercholesterolaemia and goiter, who on 01-APR-2008 was vaccinated IM in the left arm, with a dose, 0.5 mL, of pneumococcal 23v polysaccharide vaccine (Lot # 659487/1960U). Concomitant therapy included LIPITOR, oxybutynin and aspirin. On 02-APR-2008, about 24 hours after the vaccination, the patient "developed symptoms" below the injection site and spreading to her hand. The area was described as "indiscreet, warm, painful to the touch, plus erythema." The site was not swollen. The patient was seen in the office, and a BENADRYL injection (1cc) was administered, and ADVIL was prescribed. At the time of this report, the patient had not recovered. This is 1 of 2 reports from the same source. Additional information has been requested.  This is in follow-up to report (s) previously submitted on 7/30/2008.  Initial and follow up information has been received from a registered nurse, concerning a 71 year old female patient with osteoporosis, hypercholesterolaemia and goiter, who on 01-APR-2008 was vaccinated IM in the left arm deltoid, with a first dose, 0.5 ml, of pneumocuccal 23v polysaccharide vaccine (lot # 659487/19600).  Concomitant therapy included LIPITOR, oxybutynin and aspirin.  Patient had a venous dopper study done on an unspecified day.  On 02-APR-2008, about 24 hours after the vaccination, the patient "developed symptoms" below the injection site and spreading to her hand.  The area was described a "indiscreet, warm, painful to the touch, plus erythema."  The site was not swollen.  The patient was seen in the office, and a BENADRYL injection (1cc) was administered, and ADVIL and prescribed.  In follow up it was reported that patient recovered.  This is 1 of 3 reports from the same source.  Additional information has been requested.
Patient had a  general malaise unknown cause. Onsite EMS was called vitals BP 112/84 98% O2 HR 76.  Patient refused evaluation or care, released against medical advise.
Administered 12/05/02, That evening, fatigue, fever @ midnight 101.5, loss of appetite, chills, blurry vision. Went to sick case next morning, Sick in quarters for 24 hours.
Patient seen in the emergency department on 6/3 with cough, fever, fatigue, headache, and dyspnea. COVID-19 PCR testing done at that time was positive. Patient felt comfortable going home and was discharged, however returned to the emergency department on 6/5 with increased coughing and shortness of breath. He was admitted to the hospital from 6/5-6/6. This meets criteria for vaccine breakthrough case review.  Patient has been vaccinated for Covid-19, vaccination dates 1/31/2021 and 2/21/2021. Lot numbers are unavailable.
pt recvd vax 4MAR93 & devel an itchy red rash on abdo & back; 16MAR93 presented to a MD; impression was a poss viral rash that could be a react to vax; to MD w/severe joint aches & extreme difficulty walking; MD felt was severe react to vax
Fatigue at around 5pm. Chills at around 8 pm, with an underlying sense of head warmth. Fever at 9:45 pm with a headache.
This spontaneous report was received from a license practical nurse and refers two children of unknown age and gender. The patients' medical history was not provided. It was reported that the children did not have an immune response and it was suggested that the patients received a full dose of PREVNAR. So, on 23-SEP-2015, the patients were vaccinated with the 5th dose of PREVNAR (dose, route of administration, anatomical location, lot number and expiration date were not provided. On 23-OCT-2015, the patients were vaccinated with a dose of PNEUMOVAX 23, lot # K020215 (dose, route of administration, anatomical location and expiration date were not provided). There were no concomitant medications provided. On 23-OCT-2015, the patient experienced a whole arm red, injection site painful and peripheral swelling. The children did not become hospitalized. They were treated with BENADRYL and ice. On an unknown date, in 2015, the patients had immunoglobulin studies (results not provided) done because of continued recurrent problems with chronic ear, eye and nose illnesses. The outcome of erythema, peripheral swelling and injection site swelling was reported as recovered on an unspecified date in 2015. The outcome of eye disorder, nasal disorder and ear disorder was unknown. The reporter did not assess the relatedness of the events with PNEUMOVAX 23. This is one of several cases from the same reporter. Additional information has been requested.
Information has been received from a male consumer with a history of shingles who "a couple of months ago" in approximately May 2007, was vaccinated with a dose of ZOSTAVAX. Subsequently the patient developed shingles on his eyeball. No other information was provided. There was not product quality complaint involved. No further information is available.
Pt related that onset of sore arm was 5 days post vaccination. So severe that she contacted her PCP who in turn gave her a Rx for steroid medication. Condition resolved in approx 2 weeks, could barely move arm.
Information has been received from a registered nurse concerning a 16 year old female who on 17-OCT-2007, was vaccinated with a dose of GARDASIL (possible lot#'s 0523U, 1425F, 0515U) that was improperly stored reaching 32 degrees F on 4 occasions 10/02/2007, 10/03/2007, 10/09/2007 and 10/11/2007. No problems were reported. It was unknown whether medical attention was sought. There was no product quality complaint. This is one of several reports from the same source.
Syncope after vaccination requiring medical intervention to treat symptomatic hypotension.  Patient also complaining of nausea. Initial vitals 90/50, HR 65, RR 16, SPO2 100.  Given IV fluids, 50mg Benadryl and Solumedrol 125mg . BP recovered to 140/90. Transferred to local hospital via EMS.
Seriousness criteria other medically significant. Initial information received on 10 January 2007 from a health care professional. A 22 year old male patient with a past medical history of asthma received a dose of Adacel, lot number C2559AA, administered intramuscularly in the left deltoid on 22 August 2006. 20 days later, on 11 September 2006, the patient presented to his college infirmary with a cough. the cough continued and on 08 November 2006 the patient was diagnosed with left lower lobe pneumonia. On 20 December 2006, the patient was seen by an allergist. Diagnostic test were completed for Bordetella pertussis IgG and IgA. The results were as follows: PT IgG 13 units/ml (reference range <40 units/ml), PT IgA 2 units/ml (reference range <5 units/ml), FHA IgG 118 units/ml (reference range <84 units/ml), FHA IgA 47 units/ml (reference range <39 units/ml). The patient was diagnosed with pertussis and was treated with erythromycin. He recovered from the events.
Patient was administered from a vaccine that experienced a temperature excursion; Patient was administered from a vaccine that experienced a temperature excursion; This spontaneous case was reported by a physician and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Patient was administered from a vaccine that experienced a temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Patient was administered from a vaccine that experienced a temperature excursion) in an 82-year-old male patient who received mRNA-1273 (Spikevax) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Apr-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 01-Apr-2022, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Patient was administered from a vaccine that experienced a temperature excursion). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Patient was administered from a vaccine that experienced a temperature excursion). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Patient was administered from a vaccine that experienced a temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Patient was administered from a vaccine that experienced a temperature excursion) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  It was reported that the health care professional (HCP) was calling to report a temperature excursion, the reporter believed that the vaccines were okay, but the department of health instructed to call Moderna. HCP stated that the vaccines went from frozen to refrigeration temperature, so HCP believed they were okay to use. Four patients had been administered from these vaccines.  No treatment information was provided.   This case was linked to MOD-2022-541733, MOD-2022-541805, MOD-2022-541808 (Patient Link).
pt recvd vax 28JUL88 & devel a fever of 104 x 2 days & had poss sz activity;
CANNOT WALK LONG ACROSS THE YARD WITHOUT GETTING OUT OF BREATH; This spontaneous report received from a consumer via a company representative through social media concerned a male of unspecified age. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included: patient was in great health. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported.  On an unspecified date, the patient experienced cannot walk long across the yard without getting out of breath. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of cannot walk long across the yard without getting out of breath was not reported. This report was non-serious.
Severe red burning rash on arm 4in in diameter.  Experiencing chest pains and joint pains.As well as cold sweats.
This case was reported by a consumer via call center representative and described the occurrence of injection site swelling in a 76-year-old female patient who received SHINGRIX for prophylaxis. On 28th September 2018, the patient received the 1st dose of SHINGRIX .5 ml. On an unknown date, less than a month after receiving SHINGRIX, the patient experienced injection site swelling, itchy upper limbs and nocturnal awakening. On an unknown date, the outcome of the injection site swelling, itchy upper limbs and nocturnal awakening were unknown. It was unknown if the reporter considered the injection site swelling, itchy upper limbs and nocturnal awakening to be related to SHINGRIX. Additional details were reported as follows: After vaccination, the patient experienced swelling at injection site and it was just bigger than a 50-cent piece. The patient also had itching on both arms that caused her to wake up at night. The contact details of the physician was provided.
No adverse event.  HPV vaccine was given to 8y female.  Parent has observed no adverse reaction as of 9/15/10.
pt recvd vax & exp heat related injuries during physical therapy run. during run; lost consciousness; pt had a rectal t of 104.9; admitted to hosp;
So reactive and this is kicking my butt; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of malaise in a 70-year-old patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Flu unspecified (Flu vaccine) for prophylaxis.   The patient's past medical history included shingles (had a mild first outbreak 15 to 20 years back). Previously administered products included covid shot (dose received on an unknown date and reacting with each covid shot) and bivalent vaccine (dose received on an unknown date and reacting with the bi-valent one).   On 14-MAR-2023, the patient received Shingles vaccine and Flu vaccine. In MAR-2023, an unknown time after receiving Shingles vaccine and Flu vaccine, the patient experienced malaise (Verbatim: So reactive and this is kicking my butt). The outcome of the malaise was not resolved.   It was unknown if the reporter considered the malaise to be related to Shingles vaccine and Flu vaccine.     It was unknown if the company considered the malaise to be related to Shingles vaccine and Flu vaccine.   Additional Information: GSK Receipt date: 15-MAR-2023 This case was reported by a patient via interactive digital media. The patient had a mild first outbreak 15 to 20 years back.  The patient went to the doctor and now it was time for the new vaccine of two shots 2 to 6 months apart. after reacting with each covid shot and the bi-valent one, went to then get a flu shot and yesterday his/her first of the newer shingles one.  The patient having reactions the past couple years helps me cope. The patient so reactive and this one we kicking his/ her butt. still at 70, very happy to have done it. Too many stories about shingles that were awful. patient read and read and read science and testimonials.  The patient was glad he/she did. The follow-up could not be possible as no contact details were available.
Aches; Chills; menstrual like cramps (but post menopausal); Fatigue; Eye burning; low grade temp; This is a spontaneous report from a contactable nurse (patient). A 57-year-old female patient received the second dose of  bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: EL0142), via an unspecified route of administration on 06Jan2021 16:45 at a single dose on right arm for COVID-19 immunization. Medical history included, lactose intolerance. Concomitant medication included acetylsalicylic acid (ASPIRIN (E.C.), probiotics (PROBIOTICS), clarithromycin (MACROBID [CLARITHROMYCIN]), ibuprofen (MOTRIN [IBUPROFEN]), paracetamol (TYLENOL). The patient previously took Parafon Forte and experienced allergies. The patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: ek5730) on 17Dec2020 17:15 at a single dose on left arm for COVID-19 immunization. The patient experienced aches, chills, menstrual like cramps, fatigue, eye burning, and low grade temp on 07Jan2021 15:00. The outcome of the events was recovering. The events were assessed as non-serious. The facility where the most recent COVID-19 vaccine was administered was Hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19.
After I received the vaccination that evening I went to bed and woke up about midnight felt water in the bed and it was coming out of my arm, I dried it off went back to sleep. The next morning my arm was swelling, and it?s gotten worse and worse, the top of my had is so swollen I cannot make a fist. My doctor sent me to the hospital and blood work was alight the echocardiogram showed heart is alight no blood clot and there?s no other reason. My doctor thinks it?s because of the vaccination.
Info has been received from a physician concerning a 2 year old pt who was vaccinated with a 1st and 2nd dose of Haemophilus B conjugate vaccine (+) hepatitis B vaccine recombinant (yeast) on 11/03/2000 and 11/26/2001, respectively. There was no concomitant medication. Subsequently, the pt developed a break through Hib infection. At the time of infection, the pt was on amoxicillin trihydrate (+) clavulanate potassium (Augmentin). The strain of the infection was "untypable". Unspecified medical attention was sought. At the time of the report, on 12/17/2003, the pt's outcome was unknown. It was reported that the pt's immunization history included a dose of hepatitis B vaccine (manufacturer unknown) on 09/26/2000 and a 1st and 2nd dose of HIB vaccine (manufacturer unknown) on 01/05/2001 and 08/22/2001, respectively. Additional info has been requested.
Within 1 hour of receiving the vaccine the patient developed asthma symptoms,dizziness, tingling in mouth and swollen tongue. She presented at a walk-in clinic and received Epi-Pen 0.3mg, Solu-Medrol and Benadryl, while there she received 2 additional doses and was transferred to the nearest ED by ambulance. At the ED  she received a 4th dose of Epi-Pen 0.3mg and albuterol and DuoNeb treatments. She was admitted for observation. She went home and needed to return within 24 hours to the ED because her lips and tongue started to swell and she turned blue. She subsequently needed 3 additional doses of Epi-Pen over the next 24-48 hours. She has been on Benadryl 50mg every 6 hours and Famodine 20mg until present.
Sore shoulder - indicates shot may have been given to high in the shoulder. She has seen a physician and will be starting physical therapy to treat starting 10/29/18.
The first few vaccines were very typical day after symptoms and side effects; general feeling malaise. The last one I did not have a response at all. Which I found odd. However I have had a problem prior to taking the vaccines, since before the first, that my left hand started tingling and hurting occasionally. Except it starts to flare every time I take a vaccine and it's getting progressively worse with time. Not exactly sure if the vaccines that are amplifying it, I do not believe the vaccine caused it especially since it started before taking any. My muscles get weak, and sore. I was having pain up my back, my leg, etc. However it always started on my left side which is the side I had the vaccines done. I have seen multiple doctors and specialists for this and they can tell something is wrong but they can't find the source of it. I had a viral infection before I took even the first vaccine, prior to these problems started, however I tested for COVID but it came out negative. Now this is back in 2020 so it could've been COVID or it could've been something else, I just know it started after this. However, maybe the vaccines are making it worse? Not sure. I never did think so but I am documenting it just in case. Especially since the doctors are so stumped.
The patient's arm was stiff and sore when waking in the AM. The stiffness somewhat decreased but the pain increased and radiated to the axilla, elbow and shoulder.
My mother experience has been classified as in heart failure and currently in the hospital. After being vaccinated her health declined drastically.
Information has been received from a physician assistant concerning a female who was vaccinated with her second dose of GARDASIL (lot # not provided, dates of vaccination not available). On an unknown date, the patient experienced seizure like symptoms. Therapy with GARDASIL was discontinued due to the adverse event. It was unknown if the patient sought medical attention. At the time of the reporting, the patient's status was unknown. Upon internal review, seizure like symptoms was considered to be an other important medical event. Additional information has been requested.
PT COMPLAINS OF PAIN AT INJECTION SITE 1 DAY AFTER - 3 DAYS AFTER PT COMPLAINING OF TENNIS BALL LIKE PAIN AT INJECTION - NO OTHER COMPLAINTS
Patient had a seizure within two our of his TDaP vaccine. He has had more than 3 dozen seizures since this time. He was also diagnosed with Autism and major developmental delays.
Moderate pain near injection site, radiates down arm and also into shoulder/neck. Muscle aches in same areas lasting 3 days now. Short term low grade fever and headache. Pregnancy uncomplicated. Estimated date of delivery is 8/28/19.